Medable vs Cohere

Side-by-side comparison of AI visibility scores, market position, and capabilities

Cohere leads in AI visibility (90 vs 35)
Medable logo

Medable

EmergingEnterprise AI

Clinical Trials

Medable raised $304M to build the leading decentralized clinical trial (DCT) platform, enabling remote patient participation, eConsent, and wearable data integration for pharmaceutical trials.

AI VisibilityBeta
Overall Score
D35
Category Rank
#235 of 296
AI Consensus
92%
Trend
stable
Per Platform
ChatGPT
33
Perplexity
30
Gemini
30

About

Medable provides the technology infrastructure for decentralized clinical trials (DCTs) — enabling pharmaceutical companies to conduct trials where patients participate from home rather than traveling to research sites. The platform covers the full DCT workflow: electronic informed consent (eConsent), remote patient monitoring via wearables, telemedicine visits, electronic clinical outcome assessments (eCOA), and direct-to-patient drug delivery coordination.

Full profile
Cohere logo

Cohere

ChallengerAI & Machine Learning

LLM Platform

Enterprise LLM platform with $5B valuation; Command R models optimized for RAG applications with private cloud deployment competing with OpenAI and Anthropic for regulated enterprise AI.

AI VisibilityBeta
Overall Score
A90
Category Rank
#14 of 296
AI Consensus
87%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
91
Gemini
88

About

Cohere is an enterprise AI platform company providing large language model APIs, embedding models, and AI deployment infrastructure for enterprise applications — competing with OpenAI and Anthropic in the B2B LLM market but differentiating through its enterprise focus, deployment flexibility (cloud API, private cloud, or on-premises), and its Command family of models optimized for business use cases. Founded in 2019 by Aidan Gomez, Nick Frosst, and Ivan Zhang (Aidan Gomez is a co-author of the original "Attention Is All You Need" Transformer paper) in Toronto, Canada, Cohere has raised approximately $445 million at a $5 billion valuation.\n\nCohere's model portfolio includes Command (instruction-following models for enterprise tasks), Command R and Command R+ (retrieval-augmented generation-optimized models for enterprise search and document Q&A), Embed (text embedding models for semantic search and classification), and Rerank (precision reranking of search results). The Command R family is specifically optimized for RAG applications — businesses using Cohere to build intelligent search over their internal documents, knowledge bases, and data repositories.\n\nIn 2025, Cohere competes with OpenAI (GPT-4), Anthropic (Claude), and Google (Gemini) for enterprise LLM API market share, and with Mistral and Llama (Meta) for open-weight model deployments. Cohere's enterprise positioning — offering SOC 2 compliant deployment, private cloud options for regulated industries (healthcare, finance), and enterprise support SLAs — differentiates it from consumer-focused AI labs. Cohere's 2025 strategy focuses on growing its enterprise customer base in financial services, healthcare, and government sectors that require private deployment, expanding Command R's RAG capabilities for document-intensive enterprise workflows, and building a marketplace of Cohere-powered enterprise AI applications.

Full profile

AI Visibility Head-to-Head

35
Overall Score
90
#235
Category Rank
#14
92
AI Consensus
87
stable
Trend
stable
33
ChatGPT
88
30
Perplexity
91
30
Gemini
88
30
Claude
85
30
Grok
88

Key Details

Category
Clinical Trials
LLM Platform
Tier
Emerging
Challenger
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Medable
Clinical Trials
Only Cohere
LLM Platform

Integrations

Only Cohere
Cohere is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.